A keeper offers his monkeys 3 chestnuts in the morning, 4 at night. They rage. He reverses it โ 4, then 3. They're delighted. The total, 7, never changed.
Zhuangzi, ~2,300 years ago. Also: $PM vs $BTI so far year to date. ๐งต
The US majors got the level playing field they wished for.
But a level field is indiscriminate โ Midas couldn't pick what turned to gold either. It opens the door to the most PMTA-fluent supply chain on earth. It isn't American.
Full piece: https://t.co/r3RqFfs9tT
3am, Sunday, HK. The whole city's up for the World Cup. I'm up publishing a tobacco investment tracker. โฝ๏ธ๐ฌ
Every algorithm says post on a weekday. I ignored them.
This issue's theme: Be careful what you wish for ๐
@nicotinecap Yes, spot on. I would rather spend time doing something more meaningful and enjoyable. If an investor wants to go for adrenaline rush from trading, AI stocks offer far more exciting experience.
A keeper offers his monkeys 3 chestnuts in the morning, 4 at night. They rage. He reverses it โ 4, then 3. They're delighted. The total, 7, never changed.
Zhuangzi, ~2,300 years ago. Also: $PM vs $BTI so far year to date. ๐งต
The category driving all the emotion carries a weight of ~5%. Loud โ heavy โ and the market keeps confusing the two.
Full piece on what actually holds the line:
https://t.co/CTdHfRvHRi
BAT walked in as the mirror: "Velo is strong in the US."
Also true โ they raised New Category guidance. Market leaned in.
Opposite frames. Same ending: both reaffirmed full-year guidance. Only revisions were FX + non-cash adjustment.
Ahead of Big Tobacco's quarterly earnings, it's time to filter out the noise and focus on what matters. Revisit the power ranking guide for $PM, $BTI, $MO, $IMB, and $JAPAY.
Read the full, in-depth analysis before the numbers drop:
https://t.co/28m5jb00mc
Full bi-weekly tracker โ dynamic signal matrix across $PM $MO $BTI $IMB.L $2914.T plus the chronological regulatory landscape โ on Recital.
Format doesn't fit on X. Link below.
@BigBlockVette69@HundyBaggerz Yes agreed. It requires substantial scale for profitability to match combustible. Otherwise, marketing and promotional rebates eat into the margin. R&D is also a burden due to threat of competitive offerings.
@jamesforeman99 On! PLUS is gaining share but mainly driven by distribution push / gain in shelf space. Will need to wait and see whether that is sustainable.
The FDA went from punitive to permissive in 14 days.
Being first-to-authorization in US nicotine โ the moat PMI built over five years โ just got narrower.
What else the consensus missed this fortnight, in four reads ๐
Every signal is source-tagged across NielsenIQ, company IR, industry journals, and regulatory filings.
Every forward view carries a specific threshold at which it reverses.
You can audit every claim.